Low-Risk Multiple Myeloma By SKY92+ISS Validated in the Multiple Myeloma Genomics Initiative Study

被引：0

作者：

van Beers, Erik ^{[1
]}

van Vliet, Martin ^{[1
]}

de Best, Leonie ^{[1
]}

Anderson, Kenneth C. ^{[2
]}

Chari, Ajai ^{[3
]}

Jagganath, Sundar ^{[4
]}

Jakubowiak, Andrzej ^{[5
]}

Kumar, Shaji K. ^{[6
]}

Lebovic, Daniel ^{[7
]}

Levy, Joan ^{[8
]}

Auclair, Daniel ^{[8
]}

Lonial, Sagar ^{[9
]}

Reece, Donna ^{[10
]}

Richardson, Paul G. ^{[11
]}

Siegel, David ^{[12
]}

Stewart, A. Keith ^{[13
]}

Trudel, Suzanne ^{[14
]}

Vij, Ravi ^{[15
]}

Zimmerman, Todd ^{[16
]}

Fonseca, Rafael ^{[13
]}

机构：

[1] SkylineDx, Rotterdam, Netherlands

[2] Dana Farber Canc Inst, Med Oncol, Boston, MA 02115 USA

[3] Icahn Sch Med Mt Sinai, Hematol & Med Oncol, New York, NY 10029 USA

[4] Mt Sinai Med Ctr, New York, NY 10029 USA

[5] Univ Chicago, Med Ctr, Chicago, IL 60637 USA

[6] Mayo Clin, Div Hematol, Rochester, MN USA

[7] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA

[8] Multiple Myeloma Res Fdn, Norwalk, CT USA

[9] Emory Univ, Winship Canc Inst, Div BMT, Atlanta, GA 30322 USA

[10] Princess Margaret Canc Ctr, Dept Med Oncol & Hematol, Toronto, ON, Canada

[11] Harvard Univ, Sch Med, Dana Farber Canc Inst, Med Oncol, Boston, MA 02115 USA

[12] Hackensack Univ, Med Ctr, John Theurer Canc Ctr, Hackensack, NJ USA

[13] Mayo Clin, Scottsdale, AZ USA

[14] Princess Margaret Canc Ctr, Toronto, ON, Canada

[15] Washington Univ, St Louis, MO USA

[16] Univ Chicago, Chicago, IL 60637 USA

来源：

BLOOD | 2015年 / 126卷 / 23期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：5

共 50 条

[1] RISK STRATIFICATION BY SKY92+ISS OUTPERFORMS IFISH MARKERS T(4;14) AND DEL(17P) IN MULTIPLE MYELOMA
Van Vliet, M.
Kuiper, R.
Ubels, J.
Dumee, B.
Bosman, L.
van Beers, E.
de Best, L.
Waage, A.
Zweegman, S.
Morgan, G.
Goldschmidt, H.
Sonneveld, P.
HAEMATOLOGICA, 2016, 101 : 86 - 86
[2] SKY92 GEP, IFISH AND ISS COMPARISONS FOR RISK STRATIFICATION IN MULTIPLE MYELOMA
van Beers, E.
van Vliet, M.
de Best, L.
Gregory, W.
Morgan, G.
Goldschmidt, H.
Kuiper, R.
van Duin, M.
Broijl, A.
Sonneveld, P.
HAEMATOLOGICA, 2015, 100 : 258 - 258
[3] THE SKY92 PROGNOSTIC MARKER IS VALIDATED IN EIGHT MULTIPLE MYELOMA CLINICAL DATASETS
Van Vliet, M.
Kuiper, R.
Ubels, J.
Dumee, B.
Bosman, L.
van Beers, E.
de Best, L.
Waage, A.
Zweegman, S.
Morgan, G.
Levy, J.
Auclair, D.
Fonseca, R.
Goldschmidt, H.
van Duin, M.
Sonneveld, P.
HAEMATOLOGICA, 2016, 101 : 83 - 83
[4] The Multiple Myeloma Research Consortium Genomics Initiative
Trent, Jeffrey
Carpten, John
Reich, Michael
Liefeld, Ted
Keats, Jonathan
Mousses, Spyro
Hahn, William
Trudel, Suzanne
Siegel, David
Rajkumar, S. Vincent
Alsina, Melissa
Richardson, Paul
Anderson, Kenneth
Auclair, Daniel
Perkins, Louise M.
Giusti, Kathy
Fonseca, Rafael
Golub, Todd R.
BLOOD, 2007, 110 (11) : 736A - 736A
[5] Mmprofiler with SKY92 Combined with ISS Identifies High and Low Risk Multiple Myeloma in the VTD Arm of Gimema-MMY-3006
Van Beers, Erik H.
Terragna, Carolina
Martello, Marina
Zamagni, Elena
Cavo, Michele
van Vliet, Martin H.
Martinelli, Giovanni
Kuiper, Rowan
BLOOD, 2017, 130
[6] Identification of Drivers of SKY92 High-Risk Multiple Myeloma
Mcavera, Roisin
Cymer, Izabela
Mcauley, Niamh
Badar, Sarah
O'Neill, Grace
Murphy, Philip
John, Quinn
Glavey, Siobhan, V
BLOOD, 2024, 144 : 5771 - 5772
[7] Prognostic Validation of SKY92 and Its Combination With ISS in an Independent Cohort of Patients With Multiple Myeloma
van Beers, Erik H.
van Vliet, Martin H.
Kuiper, Rowan
de Best, Leonie
Anderson, Kenneth C.
Chari, Ajai
Jagannath, Sundar
Jakubowiak, Andrzej
Kumar, Shaji K.
Levy, Joan B.
Auclair, Daniel
Lonial, Sagar
Reece, Donna
Richardson, Paul
Siegel, David S.
Stewart, A. Keith
Trudel, Suzanne
Vij, Ravi
Zimmerman, Todd M.
Fonseca, Rafael
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (09): : 555 - 562
[8] SKY92 gene expression profiling and cytogenetics according to R2-ISS for multiple myeloma risk classification
Zhou, Xiang
Engel, Benedict
Hofmann, Annika
Vogt, Cornelia
Nerreter, Silvia
Teufel, Eva
Stanojkovska, Emilia
Truger, Marietta
Xiao, Xianghui
Riedhammer, Christine
Munawar, Umair
Han, Seungbin
Haertle, Larissa
Haferlach, Claudia
Einsele, Hermann
Rasche, Leo
Kortuem, Martin
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S271 - S271
[9] Analytical Validation of SKY92 for the Identification of High-Risk Multiple Myeloma
van Beers, Erik H.
Huigh, Daphne
Bosman, Lizanne
de Best, Leonie
Kuiper, Rowan
Spaan, Marieke
van Duin, Mark
Sonneveld, Pieter
Dumee, Belinda
van Vliet, Martin H.
JOURNAL OF MOLECULAR DIAGNOSTICS, 2021, 23 (01): : 120 - 129
[10] The Combination of SKY92 and ISS Provides a Powerful Tool to Identify Both High Risk and Low Risk Multiple Myeloma Cases, Validation in Two Independent Cohorts
van Vliet, Martin
Ubels, Joske
de Best, Leonie
van Beers, Erik
Sonneveld, Pieter
BLOOD, 2015, 126 (23)

← 1 2 3 4 5 →